Adaptavir

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAdaptavir
Drug Alias NameDAPTAmDAPTAMonomeric (D-Alanine1) Peptide T amideMonomeric DAPTAD-Ala1-peptide T-NH2 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsCognition DisordersHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRapid Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRapid Laboratories IncNational Institute Of Mental Health (Nimh)
Active IndicationsN/A
Inactive IndicationsCognition DisordersHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A